Skip to content
Log in Get started
Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor
Financial data updated nightly

SK Biopharmaceuticals Co Ltd

326030.KS ✓ COMPLIANTFree checks used up today ☆ Track — members
Korea Stock Exchange · Healthcare · Pharmaceuticals ·
South Korea Mid Cap Analyst: BUY
Last Close
$57.38
▲ +1.28%
Market Cap $4.50B · Vol 114.84K
Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans
Key Metrics
P/E Ratio
15.47
FWD: 16.45
Market Cap
$4.50B
Mid Cap
Div Yield
N/A
Annual dividend
EPS Growth
+36.88%
YoY
RSI (14)
22.84
Momentum
Beta
0.32
vs Market
52W High
$104.40
42.21% below
52W Low
$52.89
14.29% above
Volume
114.84K
Avg 141.30K
P/B
12.00
Price-to-book
ROE
36.17%
Return on equity
Free Float
49.86%
Public shares
Shariah Compliance8 STANDARDS
✓ Yes, SK Biopharmaceuticals Co Ltd (326030.KS) stock is Shariah compliant
You’ve used your 10 free compliance checks today

Sign up and choose a plan to keep checking — unlimited checks, all 8 standards, purification and zakat per share.

Choose a plan
  • AAOIFI—
  • Dow Jones Islamic (DJIM)—
  • FTSE Shariah—
  • MSCI Islamic—
  • S&P Shariah—
  • Al Rajhi—
  • Alinma—
  • Albilad—
Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 326030.KS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns
5D
-5.04%
1M
-9.28%
3M
-12.39%
6M
-19.92%
YTD
-36.44%
1Y
-26.26%
3Y
-16.51%
5Y
-30.22%
Financials & Valuation
TTM · Annual
Total Revenue$490.62M
Net Income$175.81M
Revenue Growth (YoY)+40.33%
Gross Margin93.93%
Operating Margin28.86%
Net Profit Margin35.83%
ROE36.17%
ROA · ROIC13.50% · 34.26%
P/E Ratio15.47
Forward P/E (FY1)16.45
PEG Ratio3.36
P/S13.81
P/B12.00
P/FCF66.46
EPS Growth+36.88%
Outstanding Shares78.31M
Technical Indicators
50-Day SMA$59.94
200-Day SMA$73.24
RSI (14)22.84
Beta0.32
52-Week High$104.40
52-Week Low$52.89
Volume Today114.84K
Avg Daily Volume (30D)141.30K
Relative Volume0.81x
Volatility (10D)26.85
Volatility (30D)40.95
Free Float49.86%
AAOIFI Certified Shariah Advisor and Auditor certificate